Check out the latest edition of our newsletter, covering updates and insights from August and September on our services and industry trends. #Logistics #MedicalTransport #ColdChain #HealthcareLogistics #Biologics #MedicalDevices #Pharma #TemperatureControl #SupplyChain
CRYOPDP
Transportation, Logistics, Supply Chain and Storage
Lifescience & Healthcare Supply Chain Solutions
About us
Everything began with a commitment to serve the life sciences and healthcare industries by offering global transport and innovative temperature-controlled logistics solutions. Being one of the market leaders in our sector and dedicated to the clinical trial and cell & gene therapy communities, we are operating in more than 150 countries intending to improve the health of people around the world. Truly focused on our customer and patient needs, we, through a dedicated team, plan, manage and implement a tailor-made temperature-controlled solution to fit your requirements and business goals. Count on us to deliver your life-saving goods worldwide - Count on CRYOPDP!
- Website
-
http://www.cryopdp.com
External link for CRYOPDP
- Industry
- Transportation, Logistics, Supply Chain and Storage
- Company size
- 201-500 employees
- Headquarters
- Roissy Charles de Gaulle cedex | France
- Type
- Self-Owned
- Specialties
- Life Science and Healthcare Logistics, Time-critical Courier service, Cold chain management, Temperature controlled logistics, Cryogenic solutions, Liquid Nitrogen, Dry Ice, Clinical Trials and R&D, Specimens, BioPharma, Cell & Gene Therapy, Central Labs, Drugs, API’s, and Packaging and Monitoring solutions
Locations
Employees at CRYOPDP
Updates
-
Advances in AI, stricter regulations, and a shift toward sustainability are set to transform the pharmaceutical industry in 2025. Industry leaders are focusing on how these trends will shape the future of drug development, clinical trials, and healthcare solutions. Want to know how these changes will impact the pharma sector? Read the full article. #PharmaInnovation #AIinPharma #SustainabilityInPharma #Regulations #ClinicalTrials #HealthcareInnovation #Pharma2025 #FutureOfPharma #PharmaTrends
Pharma Forecast 2025: Industry leaders share their predictions
pharmaceuticalmanufacturer.media
-
Molecular Glue Degraders: Revolutionizing Drug Discovery “Molecular glue degraders give companies the opportunity to go after the most impactful targets with a completely different set of rules.” – Phil Chamberlain, CEO, Neomorph. In 2024, pharmaceutical giants like Novartis and Biogen are investing heavily in this breakthrough technology, which can target previously “undruggable” proteins and has applications in oncology, neurodegeneration, and more. #MolecularGlueDegraders #PharmaInnovation #DrugDiscovery #Biotech #CancerResearch #Neurodegeneration #TherapeuticAdvances #ProteinDegradation #MedicalBreakthroughs
Molecular Glue Degraders at Inflection Point as Pharma Dives In
biospace.com
-
EMA to Review Potential Eye Risk Linked to Novo Nordisk’s Ozempic The European Medicines Agency (EMA) is investigating new studies that suggest a possible connection between Novo Nordisk’s Ozempic and the rare eye condition NAION. This is in response to 19 reported cases and a request from the Danish Medicines Agency. Read the full article here. #EMA #NovoNordisk #Ozempic #NAION #DrugSafety #HealthNews #Pharmaceuticals #RegulatoryReview #MedicalResearch
EMA to Investigate Eye Risk for Novo’s Ozempic: Reuters
biospace.com
-
TrialAssure announces a significant upgrade to its LINK® AI content creation tool for medical writing, now integrated with Microsoft Word. This new feature streamlines the document creation, helping medical writers generate accurate drafts faster and more efficiently. It addresses the pharmaceutical industry's growing needs by reducing document drafting times by weeks, ensuring compliance, and enhancing productivity across the drug development lifecycle. Learn more about how this new feature can transform the medical writing process. #Pharmaceuticals #MedicalWriting #AI #DrugDevelopment #HealthTech #ClinicalTrials #Innovation #Efficiency #TrialAssure
Generative AI Medical Writing Tool for the Pharmaceutical and Biotechnology Industries From TrialAssure Gets a Major Upgrade to Make Scientific Document Creation Easier | BioPharma Dive
biopharmadive.com
-
When patients have easy access to treatments, adherence improves, leading to stronger, more reliable clinical trial results. Our direct-to-patient logistics service removes barriers, ensuring therapies are delivered right to participants' doors—on time and safely. What we offer: - Flexible delivery options to fit patients' schedules - Temperature-controlled transport to protect treatment integrity - Tailored services focused on individual patient needs This approach enhances the patient experience, reduces dropouts, and improves clinical trial outcomes. Want to optimise your trial logistics and boost patient adherence? Learn more: https://lnkd.in/dMm2YTPq #DirectToPatient #ClinicalTrials #PatientAdherence #ImprovedOutcomes #CRYOPDP #LogisticsWithCare #HealthcareInnovation #PatientFocused #ClinicalSuccess
-
-
Transporting biological samples requires careful handling and reliable logistics to ensure accuracy and success in research and healthcare. Our temperature-controlled solutions are designed to protect the integrity of these sensitive materials from start to finish. Key benefits include: - Precise temperature management throughout the journey - Real-time tracking for complete visibility and peace of mind - Custom solutions tailored to meet the unique needs of your samples With years of expertise in biological sample logistics, we guarantee the safe, secure, and timely delivery of materials critical to advancing science and medicine. Are you looking for a trusted logistics partner for your biological samples? Let’s discuss how we can support your needs. Learn more at https://lnkd.in/gaUAEDTU #BiologicalSampleLogistics #ColdChain #PharmaLogistics #ClinicalTrials #MedicalResearch #CRYOPDP #LogisticsWithCare
-
-
Nestlé’s new protein shots aim to support weight-loss drug users by curbing hunger naturally. At $10.99 for a pack of four, they promise a GLP-1 boost to help you feel fuller longer. But can they compete with popular drugs like Wegovy and Zepbound? Find out how they stack up. #WeightLoss #Nestle #GLP1 #Wegovy #Zepbound #HealthInnovation #AppetiteControl #ObesityTreatment #Nutrition
Nestle launches protein shots for US weight-loss drug users
reuters.com
-
The HEALEY ALS Platform Trial: A New Hope for ALS Treatment Despite several setbacks, Clene Nanomedicine and Prilenia Therapeutics are progressing with promising data. Secondary endpoint wins, and biomarker results offer new hope for ALS patients. Learn more about how these trials are shaping the future of ALS treatment. #ALS #ClinicalTrials #Biotech #Innovation #Healthcare #DrugDevelopment #Neurology #MedicalResearch #Pharmaceuticals
The HEALEY Platform Trial: Quick Failures and New Hope for ALS
biospace.com
-
5 Major Clinical Trial Failures in 2024 2024 has been a year of highs and lows in drug development. While some companies celebrated breakthroughs, others faced significant setbacks. From failed schizophrenia treatments to gene therapy disappointments, these 5 clinical trials made headlines for all the wrong reasons. Find out which promising assets missed the mark and what it means for the future of drug development. #Biopharma #DrugDevelopment #ClinicalTrials #PharmaNews #HealthInnovation
5 Clinical Assets That Flopped in 2024
biospace.com